Circulating Tumor Cells (CTC) Market Insights - Industry Analysis and Forecast to 2025

1. Circulating Tumor Cells (CTC) Market Analysis, Size, Growth, Share & Forecast to 2025 | Grand View Research Inc. “CTC Market Size Worth $17.56 Billion By 2025 | CAGR 15.0%.” The global Circulating Tumor Cells Market size is anticipated to reach USD 17.56 billion by 2025 growing at a CAGR of 15.0% during the forecast period, according to a new report by Grand View Research, Inc. Introduction of novel technologies for enumeration of CTC is anticipated to fuel the market growth. Rising cases of chronic oncology diseases that depend on CTC detection and analysis, as it has enormous potential in real-time monitoring of cancer therapy over methods like imaging technologies and tumor tissue biopsy, will also drive the market. Additionally, application of CTC as biomarkers for drug discovery is a promising factor for growth in the coming years. Utilization of the CTCs in the development of tumor-specific biomarkers to optimize the selection of targeted therapies and assessment of better response to the therapy is expected to support in the market growth. CTC enrichment accounted for the largest revenue share of the global market in 2018 and is expected to continue the dominance throughout the forecast period. This is due to extensive usage in oncology research establishments and high accuracy exhibited by this technology. Microchips technology is anticipated to register the highest CAGR owing to the introduction of cluster chip technology that helps capture the clusters of tumor cells for CTC quantitation. Cancer stem cell research segment accounts for the largest revenue share of the market. Properties of the cancer stem cells of self- renewal in replenishing the growing cancer is driving the attention of organizations and researchers in CTC cancer stem cell research segment. Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/circulating-tumor- cells-market Follow Us:

2. Further key findings from the study suggest: Application of alterations in the expression profiles of EMT-associated transcriptional regulators and their molecular targets as biomarkers in EMT study is expected to serve as an impetus for diagnosis of tumor • North America led the CTC market in 2018 due to rising cases of cancer, oncology research funding, and favorable government initiatives for clinical diagnostic products • APAC is anticipated to witness the highest CAGR of over 16% from 2019 to 2025 due to infrastructural development in care centers and increased sales of CTC diagnostic tests • Rising need for new diagnosis methods for cancer has encouraged R&D in developing economies of APAC. This will help expand the region further • Fluxion Biosciences, Inc.; AdnaGen AG; Biocept, Inc.; Ikonisys, Inc.; and Sysmex Corp. are some of the key industry participants • Key companies focus on the development of novel technologies for CTC enrichment & detection through collaborations with hospitals and university-based research institutes to gain access to target population • Grand View Research has segmented the global Circulating Tumor Cells (CTC) market on the basis of technology, application, and region: CTC Technology Outlook (Revenue, USD Million, 2014 - 2025) Enrichment Methods • oEx vivo Positive Selection oIn vivo Positive Selection oNegative Selection oMicrochips oSingle Spiral Microchannel Detection Methods • oImmunocytochemical Technologies oMolecular (RNA)-based Technologies oFunctional in vitro Cell Invasion Assay oXenotransplantation Models Analysis • Follow Us:

3. CTC Application Outlook (Revenue, USD Million, 2014 - 2025) Cancer Stem Cell Research • EMT Biomarkers Development • Tumorgenesis Research • Other Applications • CTC Regional Outlook (Revenue, USD Million, 2014 - 2025) North America • oU.S. oCanada Europe • oU.K. oGermany oSpain oFrance oItaly oRussia Asia Pacific • oChina oJapan oIndia oSouth Korea oSingapore oAustralia Latin America • oBrazil oArgentina Follow Us:

4. MEA • oSouth Africa oUAE Table of Content Chapter 1. Methodology and Scope 1.1. Market Segmentation & Scope 1.2. Market Definition 1.3. Information Procurement 1.3.1. Purchased database 1.3.2. GVR’s internal database 1.3.3. Secondary sources & third party perspectives 1.3.4. Primary research 1.4. Information Analysis 1.4.1. Data analysis models 1.5. Market Formulation & Data Visualization 1.6. Data Validation & Publishing Chapter 2. Executive Summary 2.1. CTC Market Outlook, 2014 - 2025 2.2. CTC Market Segment Outlook, 2014 - 2025 2.3. Competitive Insights Chapter 3. CTC Market Variables, Trends & Scope 3.1. Market Lineage Outlook 3.1.1. Parent market outlook 3.1.2. Related/ancillary market outlook 3.2. Penetration & Growth Prospect Mapping 3.3. Product Pipeline Analysis, by Stage 3.4. User Perspective Analysis 3.4.1. Consumer behavior analysis 3.4.2. Market influencer analysis 3.4.3. Procedure cost analysis/breakdown 3.5. Technology Overview Follow Us:

5. 3.5.1. Technology timeline 3.6. Regulatory Framework 3.6.1. Reimbursement framework 3.6.2. Standards & compliances 3.7. Market Dynamics 3.7.1. Market driver analysis 3.7.1.1. Development of cluster chip technology 3.7.1.2. Potential applications of CTC in cancer management 3.7.1.3. Medical need for cancer diagnostics 3.7.1.4. Rising demand for preventive medicine & companion diagnostics 3.7.1.5. Growing cancer incidence 3.7.2. Market restraint analysis 3.7.2.1. Rare occurrence of circulating tumor cells 3.7.2.2. Lack of consistency in detection and enrichment methods 3.7.2.3. Higher preference of point-of-care testing and absence of POC adaptable CTC 3.7.3. Industry challenges 3.7.3.1. High cost of diagnostics 3.8. CTC Market Analysis Tools 3.8.1. Industry analysis - Porter’s 3.8.1.1. Supplier power: (moderate due to large number of players) 3.8.1.2. Buyer power: (moderately low due to limited number of tests for clinical use) 3.8.1.3. Substitution threat: (low due to product specificity) 3.8.1.4. Threat from new entrant: (low owing to the presence of stringent guidelines) 3.8.1.5. Competitive rivalry: (high) 3.8.2. PESTEL Analysis 3.8.2.1. Political landscape 3.8.2.2. Environmental landscape 3.8.2.3. Social landscape 3.8.2.4. Technology landscape 3.8.2.5. Legal landscape 3.8.3. Major Deals & Strategic Alliances Analysis 3.8.3.1. Joint ventures 3.8.3.2. Mergers & acquisitions Follow Us:

6. 3.8.3.3. Licensing & partnership 3.8.3.4. Technology collaborations 3.8.3.5. Strategic divestments 3.8.4. Market entry strategies 3.8.5. Case studies Chapter 4. CTC Market - Competitive Analysis 4.1. Recent Developments & Impact Analysis, by Key Market Participants 4.2. Company/Competition Categorization 4.3. Vendor Landscape 4.3.1. List of key distributors and channel partners 4.3.2. Key customers 4.3.3. Key company market share analysis, 2018 4.4. Public Companies 4.4.1. Company market position analysis 4.4.2. Company market share/ranking, by region 4.4.3. Competitive dashboard analysis 4.4.4. Market differentiators 4.4.5. Synergy analysis: major deals & strategic alliances 4.5. Private Companies 4.5.1. List of key emerging companies’ products 4.5.2. Regional network map 4.5.3. Company market position analysis 4.5.4. Supplier ranking Chapter 5. CTC Market: Technology Estimates & Trend Analysis 5.1. Definitions & Scope 5.2. Technology Market Share Analysis, 2018 & 2025 5.3. Segment Dashboard 5.4. Global CTC Market, by Technology, 2014 to 2025 5.5. Market Size & Forecasts and Trend Analyses, 2014 to 2025 for the following: 5.5.1. CTC enrichment methods market, 2014 to 2025 5.5.1.1. Market revenue (USD Million), by region 5.5.1.2. Ex vivo positive selection market, 2014 to 2025 5.5.1.2.1. Market revenue (USD Million), by region Follow Us:

7. 5.5.1.3. In vivo positive selection market, 2014 to 2025 5.5.1.3.1. Market revenue (USD Million), by region 5.5.1.4. Negative selection market, 2014 to 2025 5.5.1.4.1. Market revenue (USD Million), by region 5.5.1.5. Microchips market, 2014 to 2025 5.5.1.5.1. Market revenue (USD Million), by region 5.5.1.6. Single spiral microchannel market, 2014 to 2025 5.5.1.6.1. Market revenue (USD Million), by region 5.5.2. CTC detection methods market, 2014 to 2025 5.5.2.1. Market revenue (USD Million), by region 5.5.2.2. Immunocytochemical technologies market, 2014 to 2025 5.5.2.2.1. Market revenue (USD Million), by region 5.5.2.3. Molecular (RNA) based technologies market, 2014 to 2025 5.5.2.3.1. Market revenue (USD Million), by region 5.5.2.4. Functional in vitro cell invasion assay market, 2014 to 2025 5.5.2.4.1. Market revenue (USD Million), by region 5.5.2.5. Xenotransplantation models market, 2014 to 2025 5.5.2.5.1. Market revenue (USD Million), by region 5.5.3. CTC analysis market, 2014 to 2025 5.5.3.1. Market revenue (USD Million), by region 5.6. CTC Technology Market, by Application, 2014 to 2025 5.6.1. Market revenue (USD Million), 2014 to 2025 Chapter 6. CTC Market: Application Estimates & Trend Analysis 6.1. Definitions & Scope 6.2. Application Market Share Analysis, 2018 & 2025 6.3. Segment Dashboard 6.4. Global CTC Market, by Application, 2014 to 2025 6.5. Market Size & Forecasts and Trend Analyses, 2014 to 2025 for the following: 6.5.1. Cancer stem cell research market, 2014 to 2025 6.5.1.1. Market revenue (USD Million), by region 6.5.2. EMT biomarkers development market, 2014 to 2025 6.5.2.1. Market revenue (USD Million), by region 6.5.3. Tumorgenesis research market, 2014 to 2025 Follow Us:

8. 6.5.3.1. Market revenue (USD Million), by region 6.5.4. Other applications market, 2014 to 2025 6.5.4.1. Market revenue (USD Million), by region Chapter 7. CTC Market: Regional Estimates & Trend Analysis, by Technology and Application 7.1. CTC Market: Regional Snapshot 7.2. CTC Market: Regional Share and Leading Players, 2018 7.2.1. North America 7.2.2. Europe 7.2.3. Asia Pacific 7.2.4. Latin America 7.2.5. Middle East & Africa 7.3. North America 7.3.1. North America CTC market revenue (USD Million) 7.3.2. U.S. CTC market 7.3.2.1. U.S. CTC market, by technology 7.3.2.2. U.S. CTC market, by application 7.3.3. Canada CTC market 7.3.3.1. Canada CTC market, by gestation duration 7.3.3.2. Canada CTC market, by application 7.4. Europe 7.4.1. Europe CTC market revenue (USD Million) 7.4.2. U.K. 7.4.2.1. U.K. CTC market, by technology 7.4.2.2. U.K. CTC market, by application 7.4.3. Germany 7.4.3.1. Germany CTC market, by technology 7.4.3.2. Germany CTC market, by application 7.4.4. Spain 7.4.4.1. Spain CTC market, by technology 7.4.4.2. Spain CTC market, by application 7.4.5. France 7.4.5.1. France CTC market, by technology Follow Us:

9. 7.4.5.2. France CTC market, by application 7.4.6. Italy 7.4.6.1. Italy CTC market, by technology 7.4.6.2. Italy CTC market, by application 7.4.7. Russia 7.4.7.1. Russia CTC market, by technology 7.4.7.2. Russia CTC market, by application 7.5. Asia Pacific 7.5.1. Asia Pacific CTC market revenue (USD Million) 7.5.2. China 7.5.2.1. China CTC market, by technology 7.5.2.2. China CTC market, by application 7.5.3. Japan 7.5.3.1. Japan CTC market, by technology 7.5.3.2. Japan CTC market, by application 7.5.4. India 7.5.4.1. India CTC market, by technology 7.5.4.2. India CTC market, by application 7.5.5. South Korea 7.5.5.1. South Korea CTC market, by technology 7.5.5.2. South Korea CTC market, by application 7.5.6. Singapore 7.5.6.1. Singapore CTC market, by technology 7.5.6.2. Singapore CTC market, by application 7.5.7. Australia 7.5.7.1. Australia CTC market, by technology 7.5.7.2. Australia CTC market, by application 7.6. Latin America 7.6.1. Latin America CTC market revenue (USD Million) 7.6.2. Brazil 7.6.2.1. Brazil CTC market, by technology 7.6.2.2. Brazil CTC market, by application 7.6.3. Argentina Follow Us:

10. 7.6.3.1. Argentina CTC market, by technology 7.6.3.2. Argentina CTC market, by application 7.7. Middle East & Africa (MEA) 7.7.1. MEA CTC market revenue (USD Million) 7.7.2. South Africa 7.7.2.1. South Africa CTC market, by technology 7.7.2.2. South Africa CTC market, by application 7.7.3. UAE 7.7.3.1. UAE CTC market, by technology 7.7.3.2. UAE CTC market, by application 7.8. SWOT Analysis, by Factor (Political & Legal, Economic And Technological) 7.8.1. North America 7.8.2. Europe 7.8.3. Asia Pacific 7.8.4. Latin America 7.8.5. Middle East & Africa Chapter 8. Company Profiles 8.1. Company Profiles 8.1.1. Adnagen AG 8.1.1.1. Company Overview 8.1.1.2. Financial Performance 8.1.1.3. Product Benchmarking 8.1.1.4. Strategic Initiatives 8.1.2. Advanced Cell Diagnostics 8.1.2.1. Company Overview 8.1.2.2. Financial Performance 8.1.2.3. Product Benchmarking 8.1.2.4. Strategic Initiatives 8.1.3. Apocell 8.1.3.1. Company Overview 8.1.3.2. Financial Performance 8.1.3.3. Product Benchmarking 8.1.3.4. Strategic Initiatives Follow Us:

11. 8.1.4. Aviva Biosciences 8.1.4.1. Company Overview 8.1.4.2. Financial Performance 8.1.4.3. Product Benchmarking 8.1.4.4. Strategic Initiatives 8.1.5. Biocep Ltd. 8.1.5.1. Company Overview 8.1.5.2. Financial Performance 8.1.5.3. Product Benchmarking 8.1.5.4. Strategic Initiatives 8.1.6. Biocept Inc. 8.1.6.1. Company Overview 8.1.6.2. Financial Performance 8.1.6.3. Product Benchmarking 8.1.6.4. Strategic Initiatives 8.1.7. Biofluidica 8.1.7.1. Company Overview 8.1.7.2. Financial Performance 8.1.7.3. Product Benchmarking 8.1.7.4. Strategic Initiatives 8.1.8. Canopus Biosciences 8.1.8.1. Company Overview 8.1.8.2. Financial Performance 8.1.8.3. Product Benchmarking 8.1.8.4. Strategic Initiatives 8.1.9. CellTraffix Inc. 8.1.9.1. Company Overview 8.1.9.2. Financial Performance 8.1.9.3. Product Benchmarking 8.1.9.4. Strategic Initiatives 8.1.10. Clearbridge BioMedics 8.1.10.1. Company Overview 8.1.10.2. Financial Performance Follow Us:

12. 8.1.10.3. Product Benchmarking 8.1.10.4. Strategic Initiatives 8.1.11. Creatv Microtech Inc. 8.1.11.1. Company Overview 8.1.11.2. Financial Performance 8.1.11.3. Product Benchmarking 8.1.11.4. Strategic Initiatives 8.1.12. Cynvenio Biosystems Inc. 8.1.12.1. Company Overview 8.1.12.2. Financial Performance 8.1.12.3. Product Benchmarking 8.1.12.4. Strategic Initiatives 8.1.13. Epic Biosciences 8.1.13.1. Company Overview 8.1.13.2. Financial Performance 8.1.13.3. Product Benchmarking 8.1.13.4. Strategic Initiatives 8.1.14. Fluxion Biosciences 8.1.14.1. Company Overview 8.1.14.2. Financial Performance 8.1.14.3. Product Benchmarking 8.1.14.4. Strategic Initiatives 8.1.15. Greiner Bio-One GmbH 8.1.15.1. Company Overview 8.1.15.2. Financial Performance 8.1.15.3. Product Benchmarking 8.1.15.4. Strategic Initiatives 8.1.16. Ikonisys Inc. 8.1.16.1. Company Overview 8.1.16.2. Financial Performance 8.1.16.3. Product Benchmarking 8.1.16.4. Strategic Initiatives 8.1.17. IV Diagnostics Inc. Follow Us:

13. 8.1.17.1. Company Overview 8.1.17.2. Financial Performance 8.1.17.3. Product Benchmarking 8.1.17.4. Strategic Initiatives 8.1.18. Janssen Diagnostics 8.1.18.1. Company Overview 8.1.18.2. Financial Performance 8.1.18.3. Product Benchmarking 8.1.18.4. Strategic Initiatives 8.1.19. Miltenyi Biotech 8.1.19.1. Company Overview 8.1.19.2. Financial Performance 8.1.19.3. Product Benchmarking 8.1.19.4. Strategic Initiatives 8.1.20. Nanostring Technologies Inc. 8.1.20.1. Company Overview 8.1.20.2. Financial Performance 8.1.20.3. Product Benchmarking 8.1.20.4. Strategic Initiatives 8.1.21. Rarecells 8.1.21.1. Company Overview 8.1.21.2. Financial Performance 8.1.21.3. Product Benchmarking 8.1.21.4. Strategic Initiatives 8.1.22. ScreenCell 8.1.22.1. Company Overview 8.1.22.2. Financial Performance 8.1.22.3. Product Benchmarking 8.1.22.4. Strategic Initiatives 8.1.23. Silicon Biosystems USA 8.1.23.1. Company Overview 8.1.23.2. Financial Performance 8.1.23.3. Product Benchmarking Follow Us:

14. 8.1.23.4. Strategic Initiatives 8.1.24. Stem Cell Technologies 8.1.24.1. Company Overview 8.1.24.2. Financial Performance 8.1.24.3. Product Benchmarking 8.1.24.4. Strategic Initiatives 8.1.25. Sysmex Corporation 8.1.25.1. Company Overview 8.1.25.2. Financial Performance 8.1.25.3. Product Benchmarking 8.1.25.4. Strategic Initiatives 8.1.26. Vitatex Inc 8.1.26.1. Company Overview 8.1.26.2. Financial Performance 8.1.26.3. Product Benchmarking 8.1.26.4. Strategic Initiatives 8.2. List of companies About Grand View Research, Inc.: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email:sales@grandviewresearch.com For More Information:https://www.grandviewresearch.com Follow Us: